Skip to main content
TipRanks
Go Ultimate75% OFF

Infant Bacterial Therapeutics AB (9IB) Q2 2023 Earnings Report

4 Followers

DE:9IB Q2 2023 EPS Results

Actual EPS
-EUR 0.23
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.01

DE:9IB Q2 2023 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/25/2023
Time
Before Open
Conference Call
Friday, August 25, 2023
DE:9IB Upcoming Earnings

Infant Bacterial Therapeutics AB's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:9IB Earnings History

DE:9IB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272026 (Q4)-0.07--0.13――
Nov 13, 20262026 (Q3)-0.24-0.24-0.07-256.00% (-0.17)
Aug 26, 20262026 (Q2)-0.14-0.20-0.13-55.31% (-0.07)
May 06, 20262026 (Q1)-0.13-0.15-0.11-36.93% (-0.04)
Feb 06, 20262025 (Q4)-1.30-0.13-0.2342.94% (+0.10)
Nov 13, 20252025 (Q3)―-0.07-0.2269.06% (+0.15)
Aug 20, 20252025 (Q2)―-0.13-0.2955.08% (+0.16)
May 07, 20252025 (Q1)―-0.11-0.1939.81% (+0.07)
Feb 13, 20252024 (Q4)―-0.23-0.2717.43% (+0.05)
Nov 14, 20242024 (Q3)―-0.22-0.21-4.94% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed